trending Market Intelligence /marketintelligence/en/news-insights/trending/1402wtuk-bbr3yvpxeckaw2 content
BY CONTINUING TO USE THIS SITE, YOU ARE AGREEING TO OUR USE OF COOKIES. REVIEW OUR
PRIVACY & COOKIE NOTICE
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *

* Required

In this list

Fuse Medical makes leadership changes following investment

Street Talk Episode 41 - How to Win the Funding Battle, Use Fintech to Play Offense

Forward Spark Spreads Suggest Rising Profitability Of US Renewables As Sector Matures

MA Activity The Big Story In Mature Online Video Platform Market

Martina Cheung Backs The Quality Program


Fuse Medical makes leadership changes following investment

Christopher Reeg was appointed the CEO of Fuse Medical Inc. after he made an equity investment in the company.

Reeg acquired 4 million shares of the company for $320,000. He was joined by Mark Brooks who purchased 5 million shares for $400,000 and was appointed the chairman of the board.

Brooks and Reeg now own 57% of the company and replace Christopher Pratt and Robert Donehew, Fuse Medical's former CEO and board chairman, respectively.

The company's board size was also increased to five members. Pratt and Donehew will remain on the board and will be joined by Brooks and Reeg.

William McLaughlin III, a nominee of Brooks and Reeg, is also joining the board. Rusty Shelton and Randall Dei have resigned to make way for the additions.

Reeg is the founder and president of Maxim Surgical, which is in the business of spinal and orthopedic implants. Brooks is the CEO and McLaughlin is the CFO of CPM Medical Consultants LLC, a distributor of medical devices and regenerative tissue.